Home›Stock Screener›Jubilant Pharmova›P/E Ratio

Jubilant Pharmova P/E Ratio

Current P/E Ratio
40.31
High Valuation
Very High - High growth expectations or significantly overvalued

Jubilant Pharmova (JUBLPHARMA) P/E ratio is 40.31 (High), EPS (TTM) ₹25.15, current price ₹991.75 on NSE vs historical average P/E of 19.63 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Analyse JUBLPHARMA promoter holding to track promoter, FII and institutional holdings.

Current Valuation Metrics

P/E Ratio 40.31
Current Price ₹991.75
EPS (TTM) ₹25.15
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 19.63
Historical Range 9.61 - 39.54
Percentile 100.0%

Sector Context

Sector Average 49.1
Sector Median 28.77
Sector Rank #11 of 193
Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹31.34
Mar 2026 ₹7.55
Sept 2025 ₹7.59

JUBLPHARMA P/E Ratio — Valuation Signal & Historical Context

Jubilant Pharmova P/E 40.31 vs historical average 19.63, range 9.61–39.54 — signal: Overvalued. Browse JUBLPHARMA cash flow statement for revenue, profit, balance sheet and cash flow data.

  • Stock appears overvalued with PE of 40.31, suggesting caution for new investments
  • Current PE is 105.4% above historical average
  • Trading at discount to sector average PE of 49.1

Jubilant Pharmova P/E Ratio Historical Trend

JUBLPHARMA annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 40.31 vs historical average 19.63. For live price, revenue and the complete fundamental profile, see JUBLPHARMA share price screener.

JUBLPHARMA Historical P/E Ratio — EPS, Year-End Price & Valuation

Jubilant Pharmova annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 39.54 27.31 ₹1079.90 NSE High
2021 23.87 35.69 ₹851.80 NSE Moderate
2020 9.61 55.4 ₹532.65 NSE Low
2018 14.62 53.18 ₹777.60 NSE Low
2017 15.19 40.94 ₹621.95 NSE Moderate
2016 14.93 28.06 ₹419.05 NSE Low

JUBLPHARMA vs Healthcare Peers — P/E Ratio Comparison

Jubilant Pharmova P/E 40.31 vs Healthcare average 49.1, median 28.77 — range 0.97–869.57.

Sector Average
49.1
Sector Median
28.77
Lowest P/E
0.97
Highest P/E
869.57
Companies
193
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.97 ₹36 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.13 ₹53 Low
Sun Pharma Advanced Rese… SPARC 4.39 ₹7,561 Low
Ind Swift Laboratories INDSWFTLAB 4.61 ₹1,146 Low
Amwill Health Care AMWILL 6.04 ₹65 Low
Mono Pharmacare MONOPHARMA 6.85 ₹20 Low
Medicamen Organics MEDIORG 6.94 ₹28 Low
Brooks Laboratories BROOKS 7.38 ₹166 Low
Shelter Pharma SHELTER 7.4 ₹54 Low